In the case of the recent fast tracked FDA trials for MDMA assisted therapy, I believe those trials were being led by a non-profit organization, and they don't have any interest in patenting the drug, let alone selling it. Their interest is in the therapy aspect of it, for which cheap and readily available MDMA is a high priority. So yeah, the pharma industry isn't going to be profiting off of it, at least for MDMA.